{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T22:16:02Z","timestamp":1767046562175},"reference-count":2,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,7]]},"DOI":"10.1093\/ajhp\/zxab233","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T20:09:34Z","timestamp":1622837374000},"page":"1663-1664","source":"Crossref","is-referenced-by-count":6,"title":["Bayesian-estimated vancomycin area under the curve using a single trough concentration vs 2 concentrations"],"prefix":"10.1093","volume":"78","author":[{"given":"Dan","family":"Ho","sequence":"first","affiliation":[{"name":"Thomas J. Long School of Pharmacy and Health Sciences University of the Pacific Stockton, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jered","family":"Arquiette","sequence":"additional","affiliation":[{"name":"San Joaquin General Hospital French Camp, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myo-Kyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Thomas J. Long School of Pharmacy and Health Sciences University of the Pacific Stockton, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"issue":"11","key":"2021090712261973100_CIT0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health-Syst Pharm"},{"issue":"1","key":"2021090712261973100_CIT0002","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are vancomycin trough concentrations adequate for optimal dosing?","volume":"58","author":"Neely","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxab233\/38656764\/zxab233.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/18\/1663\/40322755\/zxab233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/78\/18\/1663\/40322755\/zxab233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T12:28:05Z","timestamp":1631017685000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/78\/18\/1663\/6291898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":2,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,6,4]]},"published-print":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxab233","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9,15]]},"published":{"date-parts":[[2021,6,4]]}}}